<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Gordon | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/woodpiano17/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/woodpiano17/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Gordon.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">3140812dfb1bd121053246aa13c06862</guid>
				<title>Gordon posted an update: Integrated drug efficacy surveillance (iDES) was formally [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41868/</link>
				<pubDate>Sat, 08 Feb 2025 11:22:28 -0800</pubDate>

									<content:encoded><![CDATA[<p>Integrated drug efficacy surveillance (iDES) was formally introduced nationally across Thailand in fiscal year 2018 (FY2018), building on a history of drug efficacy monitoring and interventions. According to the National Malaria Elimination Strategy for Thailand 2017-2026, diagnosis is microscopically confirmed, treatment is prescribed, and&hellip;<span class="activity-read-more" id="activity-read-more-41868"><a href="http://www.nationalboardinstitute.com/activity/p/41868/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">21b9481311cb63ad3db491f869a60bed</guid>
				<title>Gordon posted an update: High-priority investigations were significantly more likely [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40367/</link>
				<pubDate>Thu, 06 Feb 2025 15:58:37 -0800</pubDate>

									<content:encoded><![CDATA[<p>High-priority investigations were significantly more likely than medium- and low-priority investigations to have two or more cases among employees (p less then 0.001), two or more cases not previously linked to the workplace (p less then 0.001), or two or more exposed workplace contacts not previously identified during case interviews (p = 0.002).&hellip;<span class="activity-read-more" id="activity-read-more-40367"><a href="http://www.nationalboardinstitute.com/activity/p/40367/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e045ec804968a8a6e8af308901bf8d17</guid>
				<title>Gordon posted an update: BACKGROUND Coronavirus Disease 2019 (COVID-19) has been [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/39253/</link>
				<pubDate>Wed, 05 Feb 2025 12:10:25 -0800</pubDate>

									<content:encoded><![CDATA[<p>BACKGROUND Coronavirus Disease 2019 (COVID-19) has been associated with a hypercoagulability state. Clinical presentation can range from asymptomatic to severe illness and mortality. Thrombotic complications in COVID-19 have been associated with mortality. The incidence of systemic hypercoagulation in COVID-19 is associated with the process of&hellip;<span class="activity-read-more" id="activity-read-more-39253"><a href="http://www.nationalboardinstitute.com/activity/p/39253/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">fccdbe0796097768b6077db4c3ce2a5e</guid>
				<title>Gordon posted an update: 06; CHQ, P &#60; 0.05). In contrast, in C2C12 cells, 1mM leu [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35889/</link>
				<pubDate>Sat, 01 Feb 2025 11:45:07 -0800</pubDate>

									<content:encoded><![CDATA[<p>06; CHQ, P &lt; 0.05). In contrast, in C2C12 cells, 1mM leucine increased mTORC1 and S6K1 phosphorylation (P &lt; 0.05), which was inhibited by 2mg/ml chloroquine. Chloroquine (2mg/ml) was sufficient to disrupt mTORC1 signaling, and MyPS.</p>
<p> Chloroquine did not inhibit amino acid-induced activation of mTORC1 signaling and skeletal MPS in humans&hellip;<span class="activity-read-more" id="activity-read-more-35889"><a href="http://www.nationalboardinstitute.com/activity/p/35889/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">34d9f4352e60189714270e94b486a0ab</guid>
				<title>Gordon posted an update: Pulmonary embolism (PE) is a life-threatening condition [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34062/</link>
				<pubDate>Thu, 30 Jan 2025 11:42:38 -0800</pubDate>

									<content:encoded><![CDATA[<p>Pulmonary embolism (PE) is a life-threatening condition characterized by occlusive disease of the pulmonary vasculature. Point-of-care ultrasound (POCUS) of right ventricular strain patterns have high specificity and low sensitivity for diagnosis. Here, we describe a patient with a saddle PE and low pre-test probability who was diagnosed primarily&hellip;<span class="activity-read-more" id="activity-read-more-34062"><a href="http://www.nationalboardinstitute.com/activity/p/34062/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f4ac21cd34a98d258d37f96156780283</guid>
				<title>Gordon posted an update: The mean distribution of preoperative obstruction level [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32559/</link>
				<pubDate>Tue, 28 Jan 2025 18:59:52 -0800</pubDate>

									<content:encoded><![CDATA[<p>The mean distribution of preoperative obstruction level could be divided into the following 38% velar, 46% multilevel, and 16% infravelar obstructions. Patients with a good treatment response (defined as AHI &lt; 15/h and AHI reduction of 50%) had fewer preoperative velar obstructions compared to non-responder (17% vs. 54%, p-value = 0.006). In pati&hellip;<span class="activity-read-more" id="activity-read-more-32559"><a href="http://www.nationalboardinstitute.com/activity/p/32559/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d0b45d319385c9bda530616ef2a6a181</guid>
				<title>Gordon became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/32538/</link>
				<pubDate>Tue, 28 Jan 2025 18:55:41 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>